1. kiml777
2. mikecress
3. 302jon
4. suemoore
1.mikecress 06/18/2018
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
2.suemoore 08/09/2018
Reports Q2 EPS loss of $0.52
3.kiml777 03/20/2018
Added a nice position today.
4.kiml777 03/20/2018
Rhythm Pharmaceuticals Announces Presentation of Genetic Epidemiology of LEPR, POMC, And PCSK1 Variants at ENDO 2018
5.302jon 05/10/2018
Announces publication of data from a Phase 2 study of setmelanotide
6.mikecress 06/18/2018
$RYTM....ridiculous, what are you doing?!
7.suemoore 06/14/2018
Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW